In a groundbreaking study set to reshape our understanding of neuronal repair, researchers have unveiled a novel mechanism by which the aryl hydrocarbon receptor (AhR) modulates axon regeneration through an intricate stress–growth switch. This work, spearheaded by Halawani and colleagues, dives deep into the cellular and molecular dynamics governing nerve injury recovery, revealing insight critical for future therapies in neurodegenerative conditions and trauma.
AhR, traditionally recognized for its role in xenobiotic metabolism, emerges as a pivotal player controlling axon regrowth. The receptor’s stability and subcellular localization are tightly regulated by a complex chaperone system involving HSP90, XAP2 (encoded by the Aip gene), and p23 (encoded by Ptges3). These proteins stabilize AhR in the cytoplasm, preventing premature activation that could derail neuronal recovery processes. Early after peripheral nerve injury, specifically at one day post injury (d.p.i.), the expression of these regulatory components undergoes subtle but significant shifts, suggesting the initiation of AhR activation in dorsal root ganglia (DRGs).
The initial exploration into potential endogenous ligands activating AhR involved a focused examination of the l-kynurenine (l-Kyn) metabolic pathway. This pathway converts tryptophan into metabolites with the capacity to serve as AhR ligands. However, transcriptome analyses revealed minimal transcriptional fluctuations in key enzymatic players such as Kmo, Kyat3, Ido1, Ido2, and Tdo2 in sciatic DRGs at 1 d.p.i., indicating a limited role for this pathway in axotomy-induced AhR modulation. Further RT–qPCR assays corroborated these findings, with a downregulation of Kyat1 but no significant change in Kmo at 36 hours post-injury, underscoring the absence of major transcriptional shifts in the kynurenine route during early nerve regeneration.
To disentangle the possible influence of the gut microbiome on AhR activation and subsequent nerve repair, the researchers implemented a rigorous antibiotic regimen prior to spinal nerve ligation (SNL). They found that depleting gut bacteria did not impair neurite outgrowth in cultured DRG neurons nor axon regeneration in vivo. This highlights the independence of neuronal AhR activation from gut microbiota-derived signals in the context of peripheral nerve injury. Specifically, indole-3-propionate (IPA), a microbiota-derived AhR ligand previously implicated in axonal regeneration via immune-mediated pathways, failed to enhance neurite elongation at physiologically relevant concentrations, and higher doses paradoxically reduced outgrowth.
Given the expression of Cre recombinase under Thy1 promoter control, which is also activated in enteric neurons aside from peripheral sensory neurons, the team evaluated gut immune parameters to exclude off-target effects. Their meticulous immunophenotyping found no significant alterations in immune cell populations within the gut, reaffirming that the observed axonal phenotypes were neuron-specific rather than a consequence of systemic immune perturbations. This independence from gut immunity strengthens the argument advocating for intrinsic neuronal mechanisms as the core drivers of the regenerative response observed upon AhR inhibition.
The immune milieu within the sciatic DRGs and at nerve injury sites further supports the neuron-intrinsic nature of enhanced regeneration. Immunofluorescence analyses demonstrated no significant differences between AhR conditional knockout (AhrcKO) and control mice regarding various immune cell populations—encompassing CD45+ leukocytes, CD206+ myeloid cells, CD68+ phagocytes, and IBA1+ macrophages—both in naive and axotomized conditions. Additionally, immune subsets such as NK1.1+ natural killer cells, Ly6G+ neutrophils, and T-cell populations (CD4+ and CD8+) remained scarce and unchanged. At the crush injury site on the sciatic nerve, densities and distributions of F4/80+ macrophages and SOX10+ Schwann cells were comparably unaffected by neuronal AhR status.
Taken together, these data highlight a switch in neuronal state from stress signaling to growth promotion as the underlying biological pivot facilitated by AhR activity modulation. The receptor’s downregulation or functional inhibition lifts growth constraints, thereby unlocking regenerative programs intrinsic to sensory neurons. This cell-autonomous mechanism is distinct from, and operates independently of, peripheral immune or glial responses, marking a crucial advance in our comprehension of nerve repair.
The researchers’ approach also underscores the necessity of dissecting the temporal kinetics of molecular events post-injury. The early depletions of Aip and Ptges3 transcripts at 36 hours discernibly coincide with an acute phase of AhR pathway engagement, framing a timeline in which precise intervention could maximize regenerative outcomes. This temporal context is vital for designing targeted therapies aiming to modulate AhR function without compromising physiological homeostasis.
Moreover, the absence of significant changes in metabolic pathways traditionally associated with AhR ligand synthesis calls for a reevaluation of the molecular cues driving receptor activation in injured neurons. The disconnect from the l-Kyn pathway and gut microbiota-derived ligands necessitates further investigation into alternative endogenous AhR agonists or post-translational modificators active within sensory neurons following axotomy.
By establishing that enhanced axonal regeneration following peripheral nerve injury can be achieved through neuron-selective AhR inhibition, this study paves the way for novel therapeutic routes. Such strategies could hold promise for addressing unmet needs in nerve repair and functional recovery, particularly in conditions where axonal regrowth is limited or compromised, including peripheral neuropathies and spinal cord injuries.
In summary, Halawani et al. provide compelling evidence that AhR serves as a molecular gatekeeper balancing stress and growth signaling pathways within sensory neurons. Its inhibition fosters a pro-regenerative state while maintaining immune and glial homeostasis, offering an innovative paradigm in neuroregeneration research. The translational potential of these findings could catalyze the development of precision therapies harnessing intrinsic neuronal plasticity to restore nervous system integrity after injury.
Subject of Research: Neuroregeneration; Regulation of axon growth via aryl hydrocarbon receptor (AhR) signaling.
Article Title: AhR inhibition promotes axon regeneration via a stress–growth switch.
Article References:
Halawani, D., Wang, Y., Li, J. et al. AhR inhibition promotes axon regeneration via a stress–growth switch. Nature (2026). https://doi.org/10.1038/s41586-026-10295-z
Image Credits: AI Generated
DOI: https://doi.org/10.1038/s41586-026-10295-z
Tags: AhR receptor stability and localizationAhR stress-growth switch mechanismaryl hydrocarbon receptor axon regenerationendogenous AhR ligands l-kynurenine pathwayHSP90 chaperone system in neuronsneurodegenerative disease axon regrowthneuronal repair molecular dynamicsperipheral nerve injury dorsal root gangliatranscriptional changes in nerve injurytrauma-induced nerve repair signalingtryptophan metabolism neuronal recoveryXAP2 and p23 regulation of AhR
